OncoSec Medical Incorporated (ONCS) Social Stream
ONCOSEC MEDICAL Inc (ONCS) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ONCS.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued December 21, 2021
The Trend in the Analyst Price Target
ONCS's average price target has moved up $3.33 over the prior 20 months.
ONCS reports an average of 311.29% for its upside potential over the past 36 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
ONCS Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how ONCOSEC MEDICAL Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than nearly 100% of that group.
- ONCS has a higher upside potential (average analyst target price relative to current price) than 196.24% of all US stocks.
- ONCOSEC MEDICAL Inc's number of analysts covering the stock is greater than 4.69% of Healthcare stocks.
- To contextualize these metrics, consider that out of Healthcare stocks, ONCOSEC MEDICAL Inc's average analyst price target is higher than 30.8% of them.
Is ONCS a Buy, Hold or Sell? See the POWR Ratings now!